For personal use (buying research peptides for yourself) Risk level: Very low Reality: No documented cases of individuals prosecuted for possessing research peptides for personal use FDA focuses on companies selling, not individual users No federal law criminalizing personal possession of most research peptides (exception: HGH) Worst case scenarios: Customs seizure if importing (lose money, no criminal charges typically) Theoretical future regulation change (unlikely to be retroactive) For selling peptides Risk level: High Reality: FDA actively pursues companies making medical claims Selling as "human medicine" without approval is illegal Companies face warning letters, seizures, potential criminal charges Recent enforcement examples: Companies shut down for marketing unapproved peptides Warning letters issued frequently Criminal charges rare but possible for egregious cases For medical practitioners Risk level: Moderate Reality: Prescribing off-label through compounding pharmacies: Generally safe Operating peptide clinic properly: Legal Making false medical claims: Risk of medical board action Practicing medicine without license: Criminal For athletes Risk level: High (career consequences) Reality: Not criminal prosecution Career-ending bans possible Loss of medals, titles, sponsorships WADA testing increasingly sophisticated Learn about testing concerns in our peptides for athletic performance guide

Safety allows your fertility to turn back on
Serum levels of total vitamin B12, holotranscobalamin (holoTC), methylmalonic acid (MMA), and total homocysteine (tHcy) were measured on days 0, 7, 14, 30, 60, and 90
It takes time to support the body's internal recycling systems and build up cellular defenses
Malabsorption : Some people may have difficulty absorbing vitamin B12 from the diet due to certain medical conditions or the use of certain medications, such as proton pump inhibitors (PPIs) or H2 blockers, which reduce stomach acid production
PE-22-28 Evidence# PE-22-28's evidence comes primarily from French research groups associated with its development: TREK-1 pharmacology